Recce Pharmaceuticals Ltd

ASX:RCE.AX

0.32 (AUD) • At close June 4, 2025
Overzicht | Financiële gegevens

Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) AUD.

2025 Q22024 Q42024 Q22023 Q42023 Q22022 Q42022 Q22021 Q42021 Q22020 Q42020 Q22019 Q42019 Q22018 Q42018 Q22017 Q42017 Q22016 Q42016 Q22015 Q42015 Q22014 Q42014 Q22013 Q42013 Q2
Omzet 6.94602.3814.36503.08500.9970.640.051.07200.680.8620.4270.13900.040.1370.11400.0490.04900
Kosten van de omzet 8.3910.1730.1930.1420.0750.0790.1080.2050.0910.10.10.0290.3660.2380.2140.7030.3680.1760.0570.0280.0830.0310.0310.0170.017
Brutowinst -1.444-0.1732.1884.223-0.0753.006-0.1080.7920.549-0.050.971-0.0290.3130.6230.212-0.564-0.368-0.1360.080.086-0.0830.0180.018-0.017-0.017
Brutowinstmarge -0.20800.9190.96700.97400.7940.858-1.0080.90600.4610.7230.498-4.0490-3.4080.5850.755-3,961.6670.3720.372-85.7-85.7
Onderzoek- en ontwikkelingskosten 8.29904.7233.0854.0823.8062.4181.683.8771.2590.7260.0930.3230.1780.1940.6420.3570.14200.05400.0040.0040.0040.004
Algemene en administratieve kosten 1.0421.0191.0190.9250.9250.3070.3070.4140.4140.2080.20800000000000000
Verkoop- en marketingkosten 3.6671.2418.3961.1188.2550.9944.6150.69610.4140.192.05200000000000000
Verkoop-, algemene en administratieve kosten 4.70912.279.4147.9299.189.0414.9224.24110.8282.9462.2611.6820.8680.8550.7310.6740.7193.8840.3960.3220.0870.1140.1140.1010.101
Overige kosten 0000000000000000000000000
Bedrijfskosten 13.00812.279.4147.9299.189.0414.9224.24110.8282.9462.2611.6821.3421.2761.2441.14410.7434.0320.3510.1020.1540.1540.130.13
Bedrijfsresultaat -14.453-12.444-9.608-8.07-9.255-9.12-5.03-4.446-10.918-3.047-2.361-1.711-1.029-0.601-1.031-1.677-1.368-4.212-0.433-0.265-0.185-0.136-0.136-0.146-0.146
Bedrijfsresultaat ratio -2.0810-4.034-1.8490-2.9560-4.458-17.059-60.932-2.2030-1.513-0.697-2.415-12.0410-105.378-3.158-2.328-8,803.238-2.802-2.802-755.364-755.364
Totaal overige inkomsten en kosten netto -0.021-0.381-0.135-0.0960.0330.0320.0470.1990.0860.012-0.042-0.013-0.037-0.029-0.013-0.0160.0353.327-3.523-0-0-0-0-0-0
Inkomen voor belasting -14.473-12.825-9.743-8.166-9.223-9.088-4.984-4.247-10.832-2.985-2.404-1.724-1.065-0.63-1.044-1.693-1.333-0.884-3.956-0.265-0.185-0.136-0.136-0.146-0.146
Inkomen voor belasting ratio -2.0840-4.091-1.8710-2.9460-4.259-16.924-59.699-2.2430-1.567-0.731-2.446-12.1540-22.121-28.866-2.329-8,811.333-2.804-2.804-755.711-755.711
Belastingkosten -6.738-2.625-2.281-4.3110-3.085-0-0.926-0.64-0-1.07200000000000000
Nettowinst -7.735-10.2-7.462-3.855-9.223-6.003-4.984-3.321-10.192-2.985-1.332-1.724-1.065-0.63-1.044-1.693-1.333-0.884-3.956-0.265-0.185-0.136-0.136-0.146-0.146
Nettowinstmarge -1.1140-3.133-0.8830-1.9460-3.33-15.924-59.699-1.2430-1.567-0.731-2.446-12.1540-22.121-28.866-2.329-8,811.333-2.804-2.804-755.711-755.711
WPA (Winst Per Aandeel) -0.034-0.05-0.042-0.021-0.052-0.034-0.037-0.019-0.076-0.022-0.011-0.017-0.012-0.007-0.013-0.022-0.018-0.012-0.096-0.006-0.0090000
Verwaterde WPA -0.034-0.05-0.042-0.021-0.052-0.034-0.037-0.019-0.076-0.022-0.011-0.017-0.012-0.007-0.013-0.022-0.018-0.012-0.096-0.006-0.0090000
EBITDA -7.038-12.079-9.275-7.847-9.141-9.003-4.869-4.036-10.736-2.88-2.252-1.676-1.68-1.429-1.427-1.789-1.32-4.201-0.427-0.26-0.18-0.132-0.132-0.143-0.143
EBITDA ratio -1.0130-3.895-1.7980-2.9180-4.046-16.774-57.593-2.1010-2.471-1.658-3.342-12.840-105.121-3.114-2.286-8,582.81-2.716-2.716-740.442-740.442